Organisation
Department of Pharmaceutics
Department
Current researchers
1 - 10 of 120 results
- Chris Vervaet (Responsible)
- Justine Aelvoet (Member)
- Ilke Aernout (Member)
- Amin Ahmad (Member)
- Mohsin Ali (Member)
- Ruben Almey (Member)
- Dominika Berdecka (Member)
- Danique Berrevoet (Member)
- Louis Bouckaert (Member)
- Kevin Braeckmans (Member)
Projects
1 - 10 of 375
- A platform for the fast development of thermostable lyophilized mRNA lipid nanoparticle (LNP) vaccinesFrom7 Feb 2024 → TodayFunding: Foreign private sponsor - undefined
- Getting picobodies out of their comfort zone - Investigating the in vitro affinity maturation, folding and structure of isolated picobodiesFrom1 Jan 2024 → TodayFunding: FWO research project (including WEAVE projects)
- Unraveling the role of the immune system in the development of exuberant granulation tissue in horse woundsFrom1 Jan 2024 → TodayFunding: BOF - doctoral mandates
- Design and synthesis of inhibitors of the MEP pathwayFrom1 Jan 2024 → TodayFunding: BOF - doctoral mandates
- DEXTRACs: An innovative concept for targeted degradation of extracellular proteinsFrom1 Jan 2024 → TodayFunding: FWO research project (including WEAVE projects)
- Uncaging the potential of photopharmacology for the treatment of epilepsyFrom1 Jan 2024 → TodayFunding: FWO research project (including WEAVE projects)
- LNP-DECODE: Deciphering the adjuvants activity of lipid nanoparticle-based mRNA vaccines in primary dendritic cellsFrom1 Jan 2024 → TodayFunding: BOF - projects
- Restoring fertility by the 3R-approach : rejuvenating, replacing or reconstructing the oocyteFrom1 Jan 2024 → TodayFunding: BOF - projects
- Evaluation of formulation parameters o n the mRNA integrity within mRNA lipid nanoparticlesFrom20 Dec 2023 → TodayFunding: IOF - technology validation in lab
- Towards clinical testing of novel stabilized less toxic asparaginases for the treatment of acute lymphoblastic leukemiaFrom20 Dec 2023 → TodayFunding: IOF - technology validation in lab
Publications
21 - 30 of 1921
- Health-related quality of life in patients by COPD severity within primary care in Europe(2011)
Authors: PW Jones, Guy Brusselle, RW Dal Negro, M Ferrer, P Kardos, ML Levy, T Perez, JJ Soler-Cataluna, T van der Molen, L Adamek, et al.
Pages: 57 - 66 - Omalizumab as alternative to chronic use of oral corticosteroids in severe asthma(2019)
Authors: Paraskevi Katsaounou, Roland Buhl, Guy Brusselle, Pascal Pfister, Rafael Martinez, Ulrich Wahn, Jean Bousquet
Pages: 51 - 62 - Heterogeneity of phenotypes in severe asthmatics: the Belgian Severe Asthma Registry (BSAR)(2014)
Authors: F Schleich, Guy Brusselle, R Louis, O Vandenplas, A Michils, C Pilette, R Peche, M Manise, Guy Joos
Pages: 1723 - 1732 - Targeting interleukin-4 in asthma : lost in translation?(2012)
Authors: Tania Maes, Guy Joos, Guy Brusselle
Pages: 261 - 270 - Identification and characterization of molecular defects underlying retinal dystrophies(2011)
Authors: Frauke Coppieters
- A nonsense mutation in PDE6H causes autosomal-recessive incomplete achromatopsia(2012)
Authors: Susanne Kohl, Frauke Coppieters, Françoise Meire, Simone Schaich, Susanne Roosing, Christina Brennenstuhl, Sylvia Bolz, Maria M van Genderen, Frans CC Riemslag, the European Retinal Disease Consortium, et al.
Pages: 527 - 532 - Mepolizumab for chronic rhinosinusitis with nasal polyps(2021)
Authors: Guy Brusselle, Philippe Gevaert
Pages: 1081 - 1082 - Prevalence and burden of asthma in China : time to act(2019)
Authors: Guy Brusselle, Fanny Wai-San Ko
Pages: 364 - 366 - Chronic obstructive pulmonary disease and comorbidities through the eyes of the patient(2012)
Authors: Pauline Boeckxstaens, Marina Deregt, Piet Vandesype, Sara Willems, Guy Brusselle, An De Sutter
Pages: 183 - 191 - Treatment options in type-2 low asthma(2021)
Authors: Timothy S.C. Hinks, Stewart J. Levine, Guy Brusselle